Guangdong, Tianjin, China Related Funds
| Fund Name | Location |
| Amity Supply | New York, New York, United States |
| Galt Asset Management | Huntington, New York, United States |
| Growceanu Angel Investment | - |
| IKEA | Delft, The Netherlands, Zuid-Holland |
| N+1 Capital | Delhi, Delhi, India |
| Nanchang Xinshiji Chuangtou | China, Guangdong, Jiangxi |
| Neogen.biz | - |
| Next Blockchain Capital | - |
| Oakhouse Partners | California, San Francisco, United States |
| Peterson Group | China, Hong Kong, Hong Kong Island |
| Sequoia Consulting | California, San Mateo, United States |
| Skyline Ventures | California, Palo Alto, United States |
| SVK Crypto | England, London, United Kingdom |
| TAL Investment Counsel | British Columbia, Canada, Vancouver |
| TRI Cap | Minnesota, United States, Waite Park |
| University of New Brunswick | Canada, Fredericton, New Brunswick |
| Zhejiang Hongtu Venture Capital Management | China, Jiaxing, Zhejiang |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Frasergen | $7M | 12 Nov 2017 | Jiang'an District, Hubei, China | ||
EZlifeBio | $10M | 12 Apr 2017 | Yuexiu District, Guangdong Province, China | ||
Geneis | $1M | 07 Feb 2017 | Dongcheng District, Beijing, China | ||
First Bioscience | $463K | 20 Oct 2016 | Wuhan, Hubei, China | ||
Synbio Technologies | $3M | 06 Jul 2016 | China, Jiangsu | ||
Dewei Mingda | $3M | 20 Jan 2016 | Beijing, Beijing, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Frasergen | $7M | 12 Nov 2017 | Jiang'an District, Hubei, China | ||
EZlifeBio | $10M | 12 Apr 2017 | Yuexiu District, Guangdong Province, China | ||
Geneis | $1M | 07 Feb 2017 | Dongcheng District, Beijing, China | ||
First Bioscience | $463K | 20 Oct 2016 | Wuhan, Hubei, China | ||
Synbio Technologies | $3M | 06 Jul 2016 | China, Jiangsu | ||
Dewei Mingda | $3M | 20 Jan 2016 | Beijing, Beijing, China |
